Background To eliminate mother-to-child transmission (MTCT) of hepatitis B virus (HBV),
peripartum antiviral prophylaxis might be required for pregnant women infected with HBV …

The management of viral hepatitis in the setting of pregnancy requires special consideration.
There are five liver-specific viruses (hepatitis A, B, C, D, E), each with unique epidemiology …

Since 1982, safe and effective hepatitis B virus (HBV) vaccines have been commercially
available first derived from plasma of HBV infected persons and later from yeast cells using …

Chronic hepatitis B virus (HBV) infection follows a dynamic and variable course. At different
stages in the disease, hepatitis flares might occur, which can be challenging to predict and …

Chronic hepatitis B virus (HBV) infection due to mother-to-child transmission (MTCT) during
perinatal period remains an important global health problem. Despite standard passive …

More than 240 million people worldwide are chronically infected with hepatitis B virus (HBV).
Mother-to-child transmission remains the most important mechanism of infection in countries …

Hepatitis B virus (HBV) infection is a major public health problem in the world. Approximately
296 million people are chronically infected. In endemic areas, vertical transmission is a …

The hepatitis B virus (HBV) is an important human pathogen. Unvaccinated infants infected
through mother‐to‐child transmission (MTCT) are at> 95% risk of developing serum …

Background Preventing mother to child transmission of chronic hepatitis B infection in the
setting of a high maternal viral load is challenging. The idea has emerged from antepartum …

Hepatitis B during pregnancy presents unique management issues for both the mother and
fetus. These include the lack of a current cohesive strategy for treatment and follow-up of …